Trispecific antibodies for CD16A-directed NK cell engagement and dual-targeting of tumor cells.

about

Bispecific antibodies in cancer immunotherapy Expanding the Boundaries of Biotherapeutics with Bispecific Antibodies

P2860

Q56893015-4A134F87-E4FA-495D-8BA1-8FB19D0BD55B Q58724935-B6A1D177-CCBC-41B9-A6CD-DC16509102AB

P2860

Trispecific antibodies for CD16A-directed NK cell engagement and dual-targeting of tumor cells.

Item

http://www.wikidata.org/entity/Q47691851

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Trispecific antibodies for CD1 ...... dual-targeting of tumor cells.

@en

Trispecific antibodies for CD1 ...... dual-targeting of tumor cells.

@nl

type

Item

label

Trispecific antibodies for CD1 ...... dual-targeting of tumor cells.

@en

Trispecific antibodies for CD1 ...... dual-targeting of tumor cells.

@nl

prefLabel

Trispecific antibodies for CD1 ...... dual-targeting of tumor cells.

@en

Trispecific antibodies for CD1 ...... dual-targeting of tumor cells.

@nl

P1476

Trispecific antibodies for CD1 ...... dual-targeting of tumor cells.

@en

P2093

Carmen Herbrecht

http://www.w3.org/2001/XMLSchema#string

Eugene A Zhukovsky

http://www.w3.org/2001/XMLSchema#string

Ivica Fucek

http://www.w3.org/2001/XMLSchema#string

Kristina Ellwanger

http://www.w3.org/2001/XMLSchema#string

Markus Eser

http://www.w3.org/2001/XMLSchema#string

Martin Treder

http://www.w3.org/2001/XMLSchema#string

Michael Weichel

http://www.w3.org/2001/XMLSchema#string

Remko Griep

http://www.w3.org/2001/XMLSchema#string

Thomas Müller

http://www.w3.org/2001/XMLSchema#string

Thorsten Gantke

http://www.w3.org/2001/XMLSchema#string

P2860

Bispecific T-cell engagers for cancer immunotherapy.

Catumaxomab: clinical development and future directions

Quantification of HER expression and dimerization in patients' tumor samples using time-resolved Förster resonance energy transfer

Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2

Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia.

T cell-engaging BiTE antibodies specific for EGFR potently eliminate KRAS- and BRAF-mutated colorectal cancer cells.

A stable IgG-like bispecific antibody targeting the epidermal growth factor receptor and the type I insulin-like growth factor receptor demonstrates superior anti-tumor activity

A phase 1 study of the bispecific anti-CD30/CD16A antibody construct AFM13 in patients with relapsed or refractory Hodgkin lymphoma.

Soluble monomeric IgG1 Fc.

A bispecific antibody targeting CD47 and CD20 selectively binds and eliminates dual antigen expressing lymphoma cells

P304

673-684

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/PROTEIN/GZX043

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28981915

http://www.w3.org/2001/XMLSchema#string

Trispecific antibodies for CD16A-directed NK cell engagement and dual-targeting of tumor cells.

about

P2860

P2860

Trispecific antibodies for CD16A-directed NK cell engagement and dual-targeting of tumor cells.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698